We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

124 hedge funds and large institutions have $149M invested in Rigel Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 35 increasing their positions, 37 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,036% more call options, than puts

Call options by funds: $818K | Put options by funds: $72K

58% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 12

5% more funds holding

Funds holding: 118 → 124 (+6)

0.18% more ownership

Funds ownership: 6.29% → 6.47% (+0.18%)

5% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 37

9% less capital invested

Capital invested by funds: $163M → $149M (-$14.5M)

Holders
124
Holders Change
+6
Holders Change %
+5.08%
% of All Funds
1.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
35
Reduced
37
Closed
12
Calls
$818K
Puts
$72K
Net Calls
+$746K
Net Calls Change
-$251K

Top Buyers

Rank Fund Capital Flow
1
SCM
Soleus Capital Management
Connecticut
+$20.3M
2
Millennium Management
Millennium Management
New York
+$3.26M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.88M
4
UOC
UBS O'Connor
Illinois
+$1.2M
5
Two Sigma Investments
Two Sigma Investments
New York
+$1.07M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$9.62M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$5.03M
3
Citadel Advisors
Citadel Advisors
Florida
-$2.72M
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$2.62M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$1.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
BWM
101
BerganKDV Wealth Management
Minnesota
$13.2K – – –
PNC Financial Services Group
102
PNC Financial Services Group
Pennsylvania
$13.2K – – –
FHA
103
Flagship Harbor Advisors
Massachusetts
$13.2K +$15.9K +1,000 New
IWC
104
Integrated Wealth Concepts
Massachusetts
$13K – – –
MLICM
105
Metropolitan Life Insurance Company (MetLife)
New York
$12.5K -$2.06K -130 -12%
Nisa Investment Advisors
106
Nisa Investment Advisors
Missouri
$9K +$10.2K +640 +4,000%
IA
107
IFP Advisors
Florida
$6.54K -$16 -1 -0.5%
National Bank of Canada
108
National Bank of Canada
Quebec, Canada
$5.28K – – –
Northwestern Mutual Wealth Management
109
Northwestern Mutual Wealth Management
Wisconsin
$3.37K – – –
ASN
110
Advisory Services Network
Georgia
$2.64K – – –
TCWA
111
Ten Capital Wealth Advisors
Washington
$2.64K – – –
LWANC
112
Laurel Wealth Advisors (North Carolina)
North Carolina
$1.98K – – –
Osaic Holdings
113
Osaic Holdings
Arizona
$1.85K – – –
AF
114
Allworth Financial
California
$1.85K +$2.22K +140 New
NA
115
NewEdge Advisors
Louisiana
$1.32K – – –
WAM
116
Worth Asset Management
Texas
$1.32K – – –
BTI
117
Blue Trust Inc
Georgia
$1K – – –
CG
118
Cutler Group
California
$1K – – –
Point72 Asset Management
119
Point72 Asset Management
Connecticut
$991 +$1.19K +75 New
CCA
120
Column Capital Advisors
Indiana
$409 – – –
IAIM
121
International Assets Investment Management
Florida
$94 +$111 +7 New
LWCFA
122
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$36 – – –
HCP
123
Hexagon Capital Partners
Arkansas
$29 – – –
D.E. Shaw & Co
124
D.E. Shaw & Co
New York
– -$5.03M -335,290 Closed
ECM
125
ExodusPoint Capital Management
New York
– -$60K -4,016 Closed
2 3 4
5
6

RIGL Hedge Fund Activity: Q1 2023 in Review

124 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q1 2023, worth a combined $149M — down 8.9% from $163M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new RIGL positions and 12 closed out — a net gain of 7 holders — while 35 added to existing stakes and 37 trimmed.

The largest buyer was Soleus Capital Management, opening a new position worth an estimated $20.3M. The largest seller was Fidelity Investments, cutting an estimated $9.62M.

  • 124 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q1 2023, up from 118 in Q4 2022.
  • Funds reported $149M of Rigel Pharmaceuticals stock for Q1 2023, down 8.9% quarter-over-quarter.
  • 19 funds opened new Rigel Pharmaceuticals positions in Q1 2023 and 12 closed out, a net change of +7 holders.
  • The largest Rigel Pharmaceuticals buyer in Q1 2023 was Soleus Capital Management, an estimated $20.3M added.
  • The largest Rigel Pharmaceuticals seller in Q1 2023 was Fidelity Investments, an estimated $9.62M sold.

Based on aggregated 13F filings for Q1 2023.